PEDIATRIC INFLAMMATORY MULTISYMPTOM SYNDROME WITH SARS-CoV-2 (PIMS)
The Infectious disease and cardiology team at CHLA would like to alert you cases that have been identified at CHLA referred to as Pediatric Inflammatory Multisystem Syndrome with SARS-CoV-2 (PIMS). The manifestations range from a syndrome similar to Kawasaki Disease to Toxic shock syndrome.
Clinicians should be alert for patients with high fever that is persisting for 4 days or more, with other symptoms that may include
Mucosal changes- red, cracked lips; red tongue
Bilateral bulbar conjunctival injection without exudate
Swollen and/or red hands and feet
Cervical enlarged lymph node
Abdominal pain without another explanation
Fever for 7 or more days in an infant , for which another explanation has not been identified
Click here to read a PDF from the Royal College of Paediatrics and Child Health on cases there. Interestingly, in the UK, they note that these children may have SARS-CoV-2 PCR that is positive or negative.
CHLA is ready to treat these patients with a multidisciplinary collaborative approach, and there is a clinical plan in place to assure prompt testing and treatment.
It is also recommended to include this in your anticipatory guidance to families who have children with COVID-19 exposures with strict call back/return precautions for any of these symptoms.
Please keep the information confidential and not share on social channels as CHLA has not formally released a statement.